Cargando…

Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy

BACKGROUND: Fibrillary glomerulonephritis is a rare cause of progressive renal dysfunction, often leading to the need for dialysis within a few years. The role of immunosuppressive treatment is still uncertain although this has been tried with variable success. CASE PRESENTATION: A 56 year old woman...

Descripción completa

Detalles Bibliográficos
Autores principales: Javaid, Muhammad M, Denley, Helen, Tagboto, Senyo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885430/
https://www.ncbi.nlm.nih.gov/pubmed/17490479
http://dx.doi.org/10.1186/1471-2369-8-7
_version_ 1782133624346247168
author Javaid, Muhammad M
Denley, Helen
Tagboto, Senyo
author_facet Javaid, Muhammad M
Denley, Helen
Tagboto, Senyo
author_sort Javaid, Muhammad M
collection PubMed
description BACKGROUND: Fibrillary glomerulonephritis is a rare cause of progressive renal dysfunction, often leading to the need for dialysis within a few years. The role of immunosuppressive treatment is still uncertain although this has been tried with variable success. CASE PRESENTATION: A 56 year old woman with the antiphospholipid antibody syndrome (IgM anticardiolipin antibodies) was seen in the nephrology clinic with haematuria, proteinuria, and worsening renal function. A renal biopsy demonstrated a mesangial proliferative glomerulonephritis on light microscopy and smaller fibrils (10.6–13.8 nm in diameter) than is usual for fibrillary glomerulonephritis (typically 18–22 nm) on electron microscopy. Amyloidosis was excluded following detailed evaluation. On account of rapidly worsening renal failure she was started on cyclophosphamide and prednisolone which led to the partial recovery and stabilization of her renal function. CONCLUSION: This case highlights the need for routine electron microscopy in native renal biopsies, where the differential diagnosis is wide and varied and the light and immunofluorescence microscopic findings may be non specific.
format Text
id pubmed-1885430
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18854302007-06-01 Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy Javaid, Muhammad M Denley, Helen Tagboto, Senyo BMC Nephrol Case Report BACKGROUND: Fibrillary glomerulonephritis is a rare cause of progressive renal dysfunction, often leading to the need for dialysis within a few years. The role of immunosuppressive treatment is still uncertain although this has been tried with variable success. CASE PRESENTATION: A 56 year old woman with the antiphospholipid antibody syndrome (IgM anticardiolipin antibodies) was seen in the nephrology clinic with haematuria, proteinuria, and worsening renal function. A renal biopsy demonstrated a mesangial proliferative glomerulonephritis on light microscopy and smaller fibrils (10.6–13.8 nm in diameter) than is usual for fibrillary glomerulonephritis (typically 18–22 nm) on electron microscopy. Amyloidosis was excluded following detailed evaluation. On account of rapidly worsening renal failure she was started on cyclophosphamide and prednisolone which led to the partial recovery and stabilization of her renal function. CONCLUSION: This case highlights the need for routine electron microscopy in native renal biopsies, where the differential diagnosis is wide and varied and the light and immunofluorescence microscopic findings may be non specific. BioMed Central 2007-05-09 /pmc/articles/PMC1885430/ /pubmed/17490479 http://dx.doi.org/10.1186/1471-2369-8-7 Text en Copyright © 2007 Javaid et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Javaid, Muhammad M
Denley, Helen
Tagboto, Senyo
Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
title Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
title_full Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
title_fullStr Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
title_full_unstemmed Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
title_short Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
title_sort fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885430/
https://www.ncbi.nlm.nih.gov/pubmed/17490479
http://dx.doi.org/10.1186/1471-2369-8-7
work_keys_str_mv AT javaidmuhammadm fibrillaryglomerulonephritiswithsmallfibrilsinapatientwiththeantiphospholipidantibodysyndromesuccessfullytreatedwithimmunosuppressivetherapy
AT denleyhelen fibrillaryglomerulonephritiswithsmallfibrilsinapatientwiththeantiphospholipidantibodysyndromesuccessfullytreatedwithimmunosuppressivetherapy
AT tagbotosenyo fibrillaryglomerulonephritiswithsmallfibrilsinapatientwiththeantiphospholipidantibodysyndromesuccessfullytreatedwithimmunosuppressivetherapy